Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W599 | ISIN: NL0010545661 | Ticker-Symbol: 37C
Tradegate
27.01.25
13:55 Uhr
12,065 Euro
-0,280
-2,27 %
1-Jahres-Chart
CNH INDUSTRIAL NV Chart 1 Jahr
5-Tage-Chart
CNH INDUSTRIAL NV 5-Tage-Chart
RealtimeGeldBriefZeit
12,06512,22014:04
12,06512,22014:04
GlobeNewswire (Europe)
387 Leser
Artikel bewerten:
(2)

CNH Industrial N.V.: CNH enhances workplace safety with ergonomic technology

Finanznachrichten News

CNH enhances workplace safety with ergonomic technology

Visit CNH.comfor the full story and gallery

Basildon, October 17, 2024

Innovation at CNH goes beyond the products from our iconic brands. We continue to invest in cutting-edge solutions across our company that improve the quality of how we work and what we make. These include technologies that enhance workplace safety, efficiency, and productivity at all our global sites.

We continue to prioritize operator safety. One of the ways we are doing so is by running trials across manufacturing sites to assess operator wellbeing. We have successfully trialed ergonomic analysis technology, which helps reduce the risk of skeletal and muscular injuries. This technology uses AI to assess the ranges of an individual's movement, and then identifies how our processes can be improved. All movement data collected is fully anonymized and linked exclusively to the workstation for safety-related project use.

At our Case IH and New Holland plant in Curitiba, Brazil, a partnership with the ergonomic assessment technology company Kinebot, resulted in reduced ergonomic analysis time and better employee wellbeing.

A similar trial at our Case IH and New Holland plant in Saskatoon, Canada, resulted in zero incidents following the use of wearable devices that track and monitor the range of spine and shoulder movements of employees to ensure they are working in the most ergonomic way. This has resulted in the adoption of this technology across other CNH sites, and continues to be deployed.

Read the full story and see the tech in action at bit.ly/BreakingNewGround_en

CNH Industrial (NYSE: CNH) is a world-class equipment, technology and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Productivity, the Company provides the strategic direction, R&D capabilities, and investments that enable the success of its global and regional Brands. Globally, Case IH and New Holland supply 360° agriculture applications from machines to implements and the digital technologies that enhance them; and CASE and New Holland Construction Equipment deliver a full lineup of construction products that make the industry more productive. The Company's regionally focused Brands include: STEYR, for agricultural tractors; Raven, a leader in digital agriculture, precision technology and the development of autonomous systems; Hemisphere, a leading designer and manufacturer of high-precision satellite-based positioning, and heading technologies; Flexi-Coil, specializing in tillage and seeding systems; Miller, manufacturing application equipment; and Eurocomach, producing a wide range ofmini and midi excavators for the construction sector, including electric solutions.

Across a history spanning over two centuries, CNH has always been a pioneer in its sectors and continues to passionately innovate and drive customer efficiency and success. As a truly global company, CNH's 40,000+ employees form part of a diverse and inclusive workplace, focused on empowering customers to grow, and build, a better world.

For more information and the latest financial and sustainability reports visit: cnh.com

For news from CNH and its Brands visit: media.cnh.com

Media contacts:

Rebecca FabianAlex Ellis
North America United Kingdom
Tel. +1 312 515 2249 Tel. +44 (0)758 106 1696

mediarelations@cnh.com

Attachments

  • 20241017_PR_CNH_Ergonomic Innovation (https://ml-eu.globenewswire.com/Resource/Download/43b09df8-2bc6-4388-ad30-602dfe6f127c)
  • CNH Curitiba_Innovation (https://ml-eu.globenewswire.com/Resource/Download/0b64fd25-5058-4e49-ae05-aef28d4dddde)
  • Ergonomic_assessment_CNH CURITIBA (https://ml-eu.globenewswire.com/Resource/Download/aa229daf-8ee6-40a6-9b70-f667194e11d7)
  • Ergonomic_safety_CNH CURITIBA (https://ml-eu.globenewswire.com/Resource/Download/1e9b01c2-2dab-4e24-8cf0-ec8f4ddf3450)
  • Ergonomics_data_CNH CURITIBA (https://ml-eu.globenewswire.com/Resource/Download/2455171b-c716-459d-b1df-c66daaa831e3)

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.